News | News By Subject | News by Disease News By Date | Search News

Constipation News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Valeant (VRX), Progenics (PGNX) Shares Climb on Constipation Drug Approval     7/20/2016
FDA Extends Action Date for Progenics (PGNX), Valeant (VRX)'s NDA for Oral RELISTOR     4/4/2016
AstraZeneca PLC (AZN) Continues to Unload the Excess Fat with $70 Million Moventig Deal     3/1/2016
Synthetic Biologics (SYN)'s IBS-C Drug Meets All Endpoints in Second Phase II Study     1/20/2016
AstraZeneca PLC (AZN), Daiichi Sankyo in $825 Million Drug Tie-Up     3/19/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Sucampo Pharmaceuticals, Inc. (SCMP), Takeda Pharmaceutical Co. Ltd. (TKPYY)'s New Drug Application For AMITIZA® Dealt A Huge Setback     3/17/2014
AstraZeneca PLC (AZN), Nektar Therapeutics (CA) (NKTR) Hedge Bets on Constipation Drug     8/12/2013
Sucampo Pharmaceuticals, Inc. (SCMP) Wins Approval for Expanded Use of Amitiza in U.S.     4/23/2013
AstraZeneca PLC (AZN) Ready to File Constipation Drug Naloxegol     2/27/2013
Synergy Pharmaceuticals' Constipation Drug Meets Study Goals     1/2/2013
AstraZeneca PLC (AZN), Nektar Therapeutics (CA) (NKTR) Opioid Constipation Drug May Have Failed Phase III Study     11/14/2012
Positive Results for AstraZeneca PLC (AZN)'s Constipation Treatment     11/12/2012

News from Around the Web
Acupuncture With A Zap May Ease Constipation, China Academy Of Chinese Medical Sciences Study     9/13/2016
Constipated? Study Finds Surprising Cause, Yale University Reveals     6/9/2016
Doctors Find 11 Pounds Of Poop in Man Who Allegedly Didn't Go For 10 Years     9/3/2015
Suffering From Constipation? Self-Acupressure Can Help, University of California, Los Angeles (UCLA) Study     11/26/2014
The Safety of Daily Magnesium Oxide Treatment for Children with Chronic Constipation, Gunma University Graduate School of Medicine Study     3/8/2011
Plugged Up: Doctors See Signs of Worsening Constipation in Children, Johns Hopkins Children's Center Study     10/28/2010
OTC Drug Better for Constipation Claims Northern General Hospital     7/9/2010
Two Drugs Show Promise Against Severe Constipation; Help Chronic Cases, Terminally Ill Patients On Opiod Painkillers, Mayo Clinic Study     5/29/2008
MiraLax Safe for Chronic Constipation     7/25/2007
Medicines Made From Cow Urine And Dung     3/2/2005
World's Biggest Study Of Multi-Million Pound Health Problem Launched     2/22/2005

Press Releases
Synergy Pharma Presents Long-Term Data For Plecanatide In Chronic Idiopathic Constipation At The American College of Gastroenterology Annual Scientific Meeting     10/17/2016
Boston's Albireo Reports Positive Late Stage Data Results for Elobixibat     10/3/2016
Shionogi Release: Naldemedine Phase III Study Demonstrates Long-Term Safety And Efficacy For The Treatment Of Opioid-Induced Constipation     9/7/2016
Valeant (VRX) And Progenics (PGNX) Announce The U.S. Commercial Launch Of FDA-Approved Relistor Tablets     9/7/2016
ColonaryConcepts Initiates Phase I Study Of New Approach To Treating Chronic Constipation     8/3/2016
Progenics (PGNX) Receives $50 Million Milestone Payment Following FDA Approval Of RELISTOR Tablets For The Treatment Of Opioid-Induced Constipation In Adults With Chronic Non-Cancer Pain     7/26/2016
Ironwood (IRWD) And Allergan (AGN) Announce Supplemental New Drug Application For 72 Mcg Linaclotide In Chronic Idiopathic Constipation Has Been Accepted For FDA Review     6/9/2016
Shionogi Announces Acceptance Of New Drug Application In The U.S. For Naldemedine For The Treatment Of Opioid-Induced Constipation     6/6/2016
Synergy Pharma Presents New In Vitro Data Showing The pH-Dependent Activity Of Plecanatide Replicates That Of Naturally Occurring GI Peptide Uroguanylin     5/25/2016
Shionogi Release: Two Naldemedine Phase III Studies Show Consistent Improvement Of Opioid-Induced Constipation     5/24/2016
Synergy Pharma Presents New In Vitro Data Showing The pH-Dependent Activity Of Plecanatide Replicates That Of Naturally Occurring GI Peptide Uroguanylin     5/24/2016
Synthetic Biologics (SYN) Announces Detailed Data From Two SYN-010 Phase 2 Clinical Trials For The Treatment Of Irritable Bowel Syndrome With Constipation (IBS-C)     5/23/2016
Synergy Pharma Presents Additional Phase 3 Plecanatide Data In Chronic Idiopathic Constipation At Digestive Disease Week     5/23/2016
Synergy Pharma Announces Acceptance Of New Drug Application For Plecanatide, A Novel Uroguanylin Analog, In Chronic Idiopathic Constipation     4/19/2016
Shionogi Submits New Drug Applications In Japan And The U.S. For Naldemedine For The Treatment Of Opioid-Induced Constipation     3/30/2016

//-->